Phathom Pharmaceuticals Inc (PHAT)
$5.74 -7.72% Close Oct 30, 2026 Live
Phathom Pharmaceuticals stock today
Phathom Pharmaceuticals closed at $5.74 on October 30, 2026, down 7.72% on the day. Over the past year it returned -56.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $464 million.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | PHAT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -21.4% | -0.9% |
| 3 months | -36.4% | +2.1% |
| Year to date | -65.4% | +11.7% |
| 1 year | -56.9% | +12.4% |
| 3 years | -36.1% | +88.5% |
| 5 years | -75.6% | +76.0% |
Key statistics
- Market value
- $464M
- Forward P/E
- 7.2
- Price / sales
- 1.7
- 52-week range
- $5.74 to $18.08
About Phathom Pharmaceuticals
Biopharmaceutical company developing gastrointestinal medications including acid reflux treatments.
Sector: Health Care
More on Phathom Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +217% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $243.94 today
No forecast, no recommendation. This page describes Phathom Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.